Botanix Pharmaceuticals Limited (BXPHF)
USD 0.25
(0.0%)
USD 0.25
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 601.82 Thousand | 914.97 Thousand | 2.75 Million | 6.88 Million | 7.57 Million | 4.68 Million |
| Cost of Revenue | 3.65 Million | 3.96 Million | 143.49 Thousand | 94.22 Thousand | 102.28 Thousand | 1581.00 |
| Gross Profit | -3.05 Million | -3.04 Million | 2.61 Million | 6.79 Million | 7.47 Million | 4.68 Million |
| Operating Expenses | 601.82 Thousand | 9.74 Million | 15.94 Million | 10.26 Million | 24.25 Million | 21.45 Million |
| Selling, General and Administrative Expenses | 11.3 Million | 4.02 Million | 3.55 Million | 2.24 Million | 8.25 Million | 3.18 Million |
| Research and Development Expenses | 1.81 Million | 5.72 Million | 10.29 Million | 6.57 Million | 13.69 Million | 16.63 Million |
| Other Expenses | - | 3.65 Million | 2.77 Million | 6.88 Million | 7.39 Million | 4.3 Million |
| Cost and Expenses | 16.76 Million | 13.71 Million | 15.94 Million | 10.26 Million | 24.25 Million | 21.45 Million |
| Operating Income | -14.69 Million | -12.79 Million | -13.13 Million | -3.27 Million | -16.67 Million | -17.02 Million |
| Interest Expense | 10.65 Thousand | 81.73 Thousand | 37.44 Thousand | 55.94 Thousand | 50.98 Thousand | 11.2 Thousand |
| Income Tax Expense | - | -3.66 Million | 2.8 Million | 6.94 Million | 7.44 Million | 4.31 Million |
| Earnings before Tax | -13.86 Million | -12.82 Million | -13.17 Million | -3.33 Million | -16.73 Million | -17.03 Million |
| Net Income | -13.86 Million | -9.15 Million | -13.17 Million | -3.33 Million | -16.73 Million | -17.03 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.00 | -0.02 | -0.02 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.01 | -0.00 | -0.02 | -0.02 |
| Weighted Average Shares Outstanding | 1.5 Billion | 1.15 Billion | 973.14 Million | 972.93 Million | 936.37 Million | 760.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.5 Billion | 1.15 Billion | 973.14 Million | 972.93 Million | 936.37 Million | 760.48 Million |
| Gross Margin | -5.07 | -3.33 | 0.95 | 0.99 | 0.99 | 1.00 |
| EBIT Margin | -22.91 | -13.86 | -4.72 | -0.46 | -2.19 | -3.63 |
| Profit Margin | -23.05 | -10.00 | -4.78 | -0.48 | -2.21 | -3.64 |
| EBITDA | -13.78 Million | -8.96 Million | -12.98 Million | -3.18 Million | -16.57 Million | -17.15 Million |
| Earnings Before Tax Margin | -24.43 | -13.98 | -4.77 | -0.48 | -2.20 | -3.63 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 1.03 Million | 845.77 Thousand | 845.77 Thousand | 377.93 Thousand | 188.96 Thousand | 914.97 Thousand |
| Cost of Revenue | 7.15 Million | 1.33 Million | 1.33 Million | 3.4 Million | 489.1 Thousand | 3.96 Million |
| Gross Profit | -6.11 Million | -491.21 Thousand | -491.21 Thousand | -3.02 Million | -300.13 Thousand | -3.04 Million |
| Operating Expenses | 9.34 Million | 3.92 Million | 3.92 Million | 2.5 Million | 2.45 Million | 9.74 Million |
| Selling, General and Administrative Expenses | - | 3.5 Million | 3.5 Million | 1.52 Million | 2.14 Million | - |
| Research and Development Expenses | - | 417.36 Thousand | 417.36 Thousand | 978.2 Thousand | 489.1 Thousand | - |
| Other Expenses | -1.83 Million | - | - | - | - | 3.65 Million |
| Cost and Expenses | 16.49 Million | 5.26 Million | 5.26 Million | 5.9 Million | 2.94 Million | 13.71 Million |
| Operating Income | -15.45 Million | -4.41 Million | -4.41 Million | -5.52 Million | -2.76 Million | -12.79 Million |
| Interest Expense | 10.65 Thousand | 4032.00 | - | 6627.00 | - | 81.73 Thousand |
| Income Tax Expense | -1.46 Million | -1.46 Million | 182.66 Thousand | -1.00 | - | -3.66 Million |
| Earnings before Tax | -15.33 Million | -4.2 Million | -4.2 Million | -5.46 Million | -2.73 Million | -12.82 Million |
| Net Income | -13.86 Million | -4.2 Million | -4.2 Million | -5.46 Million | -2.73 Million | -9.15 Million |
| Earnings Per Share Basic | - | -0.00 | -0.00 | -0.00 | -0.00 | - |
| Earnings Per Share Diluted | - | -0.00 | -0.00 | -0.00 | -0.00 | - |
| Weighted Average Shares Outstanding | 1.5 Billion | 1.56 Billion | 1.56 Billion | 1.43 Billion | 1.43 Billion | 1.15 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.5 Billion | 1.56 Billion | 1.56 Billion | 1.43 Billion | 1.43 Billion | 1.15 Billion |
| Gross Margin | -5.91 | -0.58 | -0.58 | -8.00 | -1.59 | -3.33 |
| EBIT Margin | - | -4.97 | -4.97 | -14.60 | -14.60 | - |
| Profit Margin | -13.41 | -4.97 | -4.97 | -14.47 | -14.47 | -10.00 |
| EBITDA | - | -4.2 Million | -4.2 Million | -5.51 Million | -2.75 Million | - |
| Earnings Before Tax Margin | -14.94 | -5.22 | -5.22 | -14.62 | -14.62 | -13.98 |
JSWENERGY
8050
NOSUF
0101
CFNB
3626